When it comes to health, we can achieve something better. From discovering new ways to treat troubling conditions to prevention of diseases before they start, we believe progress should never stop.

Lab Test

Endomysial Antibody, IgA

Dermatitis Herpetiformis, Celiac Disease, Tropical Sprue

Test Codes

EPIC: LAB5755, SOFT: ENDOA

Department

Special Chemistry

Specimen Collection Criteria

Collect: One Gold-top SST tube. (Minimum Whole Blood: 2.0 mL)

Physician Office/Draw Specimen Preparation

Let specimen clot 30-60 minutes then immediately centrifuge to separate serum from cells. Refrigerate (2-8°C or 36-46°F) the centrifuged collection tube within two hours of collection. (Minimum Serum: 0.5 mL)

Preparation for Courier Transport

Transport: Centrifuged collection tube, refrigerated (2-8 °C or 36-46 °F). (Minimum Serum: 0.5 mL)

Rejection Criteria

Plasma specimens.

Severely hemolyzed, lipemic or icteric specimens.

In-Lab Processing

Let specimen clot 30-60 minutes then immediately centrifuge to separate serum from cells. Room temperature is acceptable for a maximum of two hours. (Minimum Serum: 0.5 mL)

Storage

Specimen Stability for Testing:

Centrifuged SST Tubes and Microtainers® with Separator Gels
Room Temperature (20-26°C or 68-78.8°F): 2 hours
Refrigerated (2-8°C or 36-46°F): 7 days
Frozen (-20°C/-4°F or below): Unacceptable

Red-top Tubes and Microtainers® without Separator Gels
Room Temperature (20-26°C or 68-78.8°F): 2 hours
Refrigerated (2-8°C or 36-46°F): Unacceptable
Frozen (-20°C/-4°F or below): Unacceptable

Serum Specimens (Pour-Overs)
Room Temperature (20-26°C or 68-78.8°F): 2 hours
Refrigerated (2-8°C or 36-46°F): 7 days
Frozen (-20°C/-4°F or below): 3 months

Specimen Storage in Department Prior to Disposal:

Refrigerated (2-8°C or 36-46°F): 7 days

Laboratory

Royal Oak Special Testing Laboratory

Performed

Tuesday.
Results available the same day as testing performed.

Reference Range

Less than 1:5.

Test Methodology

Indirect Immunofluorescence Assay (IFA).

Interpretation

  • IgA-endomysial antibody (IgA-EMA) is highly specific for celiac disease or dermatitis herpetiformis. Seventy to eighty percent of patients with celiac disease or dermatitis herpetiformis have circulating IgA-EMA.
  • Titer values generally correlate with the severity of gluten-sensitive enteropathy.
  • IgA-EMA titer values should begin to decrease within 6-12 months if patients strictly adhere to a gluten-free diet.

Clinical Utility

  • Endomysial antibodies are useful to screen high-risk populations (e.g. first degree relatives of celiac patients, insulin dependent diabetics, etc.) for celiac disease. However, histologic confirmation is required for diagnosis. Patients should not begin a gluten-free diet until after intestinal biopsy has been performed and the diagnosis is established. Serial celiac antibody titers may at times be useful to monitor dietary compliance.
  • Patients with IgA deficiency may have falsely negative test results. If there is a high degree of suspicion for celiac disease in a patient with IgA deficiency, tissue transglutaminase antibodies (IgG) level should be requested.

CPT Codes

86255
LOINC: 27038-9

Contacts

Last Updated

6/16/2021

Microtainer® and Vacutainer® are registered trademarks of Becton, Dickinson and Company.
UroVysion® is a registered trademark of Abbott Laboratories. ThinPrep® is a registered trademark of Hologic, Incorporated.